August 26, 2026
1 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
First device to continuously monitor ketone and glucose levels receives FDA authorization
The FDA has authorized for commercial use a wearable device for continuous monitoring of ketone and glucose levels in patients with diabetes aged at least 2 years, the agency and Abbott announced. The device (Libre Duo 10 Day system, Abbott Diabetes) is the first in the world to continuously monitor both ketone and glucose and the first in the U.S. approved to continuously monitor ketone levels,
856 words~4 min read
